Windlas Biotech Ltd Share Price
(WINDLAS)
₹974.9
as on 04:01PM, 29 Apr 2025
Windlas Biotech Performance
Day's Low
Day's High
₹967.1Day's Price Range₹1,02952 Week's Low
52 Week's High
₹495.6552-Week Price Range₹1,198.25
| Returns % | |
| 1 Month Return | -4.03 % |
| 3 Month Return | + 0.68 % |
| 1 Year Return | + 76.37 % |
| Market Stats | |
| Previous Close | ₹988.40 |
| Open | ₹997.90 |
| Volume | 57.53K |
| Upper Circuit | ₹1,186.00 |
| Lower Circuit | ₹790.80 |
| Market Cap | ₹2,037.57Cr |
Windlas Biotech Fundamentals
P/E Ratio
32.96
PEG Ratio
7.47
Market Cap
₹2,037.57 Cr
P/B Ratio
2.37
EPS
27.98
Dividend Yield
1.07
Sector
Pharmaceuticals
ROE
13.63
Mutual Fund Holdings of Windlas Biotech
Key events for Windlas Biotech Ltd
Windlas Biotech Schedules Investor Engagement Meeting - 12 Mar, 2025
Windlas Biotech Ltd. has announced a virtual investor meeting on March 17, 2025, aimed at enhancing stakeholder engagement and ensuring transparency in operations.Windlas Biotech Hits Upper Circuit After Bulk Deal - 20 Feb, 2025
Windlas Biotech shares surged 20% to Rs 811.20 following a bulk deal. The company reported strong financial growth, with a 22% YoY EBITDA increase.
Insights on Windlas Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Price Rise
In the last 1 year, WINDLAS stock has moved up by 80.1%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 9 quarters, 121.87 Cr → 199.13 Cr (in ₹), with an average increase of 5.9% per quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 1.55% to 1.52% in Mar 2025 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 7.11% to 6.70% in Mar 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 25.68% to 25.25% in Mar 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 15.66 Cr → 15.58 Cr (in ₹), with an average decrease of 0.5% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 62.51% to 62.34% in Mar 2025 quarter
Windlas Biotech Financials
Windlas Biotech Index Inclusions
Windlas Biotech Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 62.34% | 0.00 | |
| Foreign Institutions | 1.52% | 0.00 | |
| Mutual Funds | 6.7% | 0.00 | |
| Retail Investors | 25.25% | 0.00 | |
| Others | 4.19% | 0.00 |
Windlas Biotech Key Indicators
Windlas Biotech Valuation
Windlas Biotech in the last 5 years
Lowest (10.46x)
March 28, 2023
Today (32.96x)
April 29, 2025
Industry (54.77x)
April 29, 2025
Highest (38.93x)
December 6, 2024
Windlas Biotech Earnings and Dividends
Windlas Biotech Ltd Earnings Results
Windlas Biotech Ltd’s net profit jumped 3.18% since last year same period to ₹15.58Cr in the Q3 2024-2025. On a quarterly growth basis, Windlas Biotech Ltd has generated -0.51% fall in its net profits since last 3-months.
Read More about Earnings ResultsWindlas Biotech Ltd Dividends May,2024
In the quarter ending March 2024, Windlas Biotech Ltd has declared dividend of ₹5.50 - translating a dividend yield of 0.56%.
Read More about Dividends
Windlas Biotech Technicals Summary
Bearish
Neutral
Bullish
Windlas Biotech Ltd is currently in a Bearish trading position according to technical analysis indicators.
Windlas Biotech Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹2,037.57 Cr | 27.89% | 0.51 | ₹58 Cr | ₹630 Cr | |
| NA | ₹147.07 Cr | 35.43% | 0.62 | NA | NA | |
| NA | ₹5,411.31 Cr | 432.02% | 0.50 | ₹33 Cr | ₹204 Cr | |
| NA | ₹1,510.04 Cr | 381.87% | 0.52 | NA | NA | |
| NA | ₹3,596.41 Cr | 157.18% | 0.51 | NA | NA |
About Windlas Biotech
Revenue: ₹195.02Cr as on December 2024 (Q4 24)
Net Profit: ₹15.58Cr as on December 2024 (Q4 24)
Listing date: 16 Aug, 2021
Chairperson Name: Vivek Dhariwal
| Organisation | Windlas Biotech |
| Headquarters | Gurgaon |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Windlas Biotech Ltd
What is Windlas Biotech Ltd price today?
Windlas Biotech Ltd share price today stands at ₹974.9, Open: ₹997.9, Previous Close: ₹988.4, High: ₹1029, Low: ₹967.1, 52 Week High: ₹1198.25, 52 Week Low: ₹495.65.
How to Buy Windlas Biotech Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Windlas Biotech Ltd shares
What are today's traded volumes of Windlas Biotech Ltd?
Today's traded volume of Windlas Biotech Ltd(WINDLAS) is 57.53K.
What is today's market capitalisation of Windlas Biotech Ltd?
Today's market capitalisation of Windlas Biotech Ltd(WINDLAS) is ₹2037.57Cr.
What is the 52 Week High and Low Range of Windlas Biotech Ltd?
How much percentage Windlas Biotech Ltd is down from its 52 Week High?
Windlas Biotech Ltd (WINDLAS) share price is ₹974.9. It is down -18.64% from its 52 Week High price of ₹1198.25
How much percentage Windlas Biotech Ltd is up from its 52 Week low?
Windlas Biotech Ltd (WINDLAS) share price is ₹974.9. It is up 96.69% from its 52 Week Low price of ₹495.65